Frailty and Sarcopenia Outcomes in Emergency General Surgery
NCT ID: NCT03534765
Last Updated: 2019-01-10
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Total Enrollment
294 participants
Study Classification
OBSERVATIONAL
Study Start Date
2018-10-01
Study Completion Date
2020-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. A retrospective scoping cohort review of adult patients undergoing emergency laparotomy/laparoscopy for acute gastrointestinal (GI) pathology who have had a CT scan of the abdomen(+/- pelvis). CT measured sarcopenia would be compared with clinical outcomes, 30-day and 1-year mortality.
2. A prospective observational cohort study and bio-banking exercise of routinely collected clinical data, in a cohort of patient undergoing emergency laparotomy/laparoscopy or conservative treatment for an otherwise operable pathology. An interrogation of CT measured sarcopenia and a validated clinical frailty score would be analysed against clinical outcomes, 30-day and 1-year mortality.
The investigators aim to research the association and predictive advantage of combining subjectively measured frailty, objectively measured CT sarcopenia and other risk predicting tools used in every day surgical practice and surgical outcomes (mortality and morbidity) in a cohort of acute surgical patients undergoing surgery or conservative treatment.
2. A prospective observational cohort study and bio-banking exercise of routinely collected clinical data, in a cohort of patient undergoing emergency laparotomy/laparoscopy or conservative treatment for an otherwise operable pathology. An interrogation of CT measured sarcopenia and a validated clinical frailty score would be analysed against clinical outcomes, 30-day and 1-year mortality.
The investigators aim to research the association and predictive advantage of combining subjectively measured frailty, objectively measured CT sarcopenia and other risk predicting tools used in every day surgical practice and surgical outcomes (mortality and morbidity) in a cohort of acute surgical patients undergoing surgery or conservative treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association of Preoperative Sarcopenia and Intraoperative Hypotension in Patients Undergoing Minimally Invasive Pylorus Preserving Pancreaticoduodenectomy : Prospective Observational Study
NCT05320978
Patients Undergoing Minimally Invasive Pylorus Preserving Pancreaticoduodenectomy
UNKNOWN
Does Frailty Help Predict Postoperative Outcomes in Cardiac Surgery?
NCT02749149
Coronary Heart Disease
Heart Valve Diseases
UNKNOWN
Frailty in Vascular Patients Undergoing Surgery
NCT03668821
Vascular Diseases
Carotid Artery Diseases
Aneurysmal Disease
+1 more
UNKNOWN
Clinical Frailty Scale Validation in Patients Scheduled for Vascular Surgery
NCT03403673
Vascular Diseases
UNKNOWN
Early Identification of Patients in Surgical Intensive Care With a Risk of Acute Respiratory Distress Following Visceral Surgery
NCT03289975
Digestive Surgery
Urinary Surgery
COMPLETED
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Frailty has a significant impact on surgical outcomes. It is an independent risk factor for adverse outcomes following surgery including complications, length of stay, inability to return home and mortality. Frailty is a physiological decline across multiple body systems accumulating in loss of reserves and increased vulnerability to stressors.
Sarcopenia, loss of muscle mass or progressive reduction in muscle mass, is one of the central physiological manifestations of frailty resulting in weight loss, weakness and exhaustion. Frailty has both a strong correlation with age as well as significant overlap with disability and co-morbidity. Further factors strongly influencing outcome, 30 day and mortality have been described including polypharmacy, Charlson co-morbidity index, age, not independently mobile, emergency admission and falls. It has been recognised that poor outcomes are multimodal relating to the interplay of co-morbidities, physical functioning and nutrition.
Assessing frailty can be completed using simple questionnaire tools, as well as more complex assessment of co-morbidity, functional status, and disability. There is good evidence the simple tools can be as accurate as formal geriatric assessments.
As sarcopenia relates directly to many manifestations of frailty it can be used as a surrogate marker. One of the favoured ways for diagnosing sarcopenia is using CT morphometric biological markers. This uses an axial image at the level of the 3rd lumbar vertebra (L3) to assess the total or cross-sectional volume of the psoas muscle, giving rise to indices measuring muscle mass, visceral adipose tissue and subcutaneous adipose tissue.
Major abdominal emergency surgery is a high-risk procedure with ongoing audit and outcome monitoring. Currently data collection for UK National Emergency Laparotomy Audit (NELA) is in its fourth year with annual reports into the management and outcomes of emergency laparotomies. Observation and audit of these outcomes remain central to improving service and healthcare both regionally and nationally. Furthermore, this group of patients is not well represented in research and is one of the most understudied surgical cohorts that exist. This is especially the case for patients presenting with an acute surgical diagnosis and are deemed unable to withstand the stress of surgery, and hence pursue a conservative or radiological treatment option. With our ageing, co-morbid population this is becoming increasing common. The diagnosis of frailty and sarcopenia are a significant measurable and modifiable risk factor that impacts on perioperative surgical care, healthcare provider and patient decision-making and most importantly long and short term outcomes. This urgently requires further audit and study.
Work package one (WP1): Retrospective scoping cohort study in acute general surgery
Patient identification The number of patients recruited from each participating hospital will be proportionate to the total number of cases, in accordance with relative annual case volumes (as reported by NELA - in the case of less than 100% case capture, the theoretical 100% case number will be used). This will provide a representative sample of the recruiting region's population.
The most recent laparotomy cases with 1-year follow-up mortality data available will be included at the time of study activation. Data collection over a predicted six week period will be undertaken or until the sample size is reached. Retrospective collection of routinely recorded clinical data will be performed (See appendix data collection tool). This includes, but is not restricted to \[a\] routine clinical variables: patient characteristics, demographic, pathological and physiological variables will be captured in line with NELA data, alongside confounding factors associated with frailty and sarcopenia.
Protocol for measuring muscle radiation attenuation Inclusion: Retrievable CT abdomen/pelvis on an electronic NHS PACS system. CT can be non-contrast or with contrast, supine or prone but must be of sufficient quality for the sarcopenia CT analyses software to handle (Slico-matic™, TomoVision, Magog, Canada ).
Exclusion: CT-scans with large radiation artefacts or with missing parts of muscle tissue on the ventral, dorsal, or both lateral edges of the scan preventing sarcopenia assessment.
Patients meeting inclusion criteria will have their CT extracted and reviewed by a trained independent party. This may through an allocated representative at the base hospital or the CT can be extracted and sent in a fully anonymised format to the central unit for sarcopenia assessment. CT scans obtained via a PACS system can up transferred through secure inter-hospital PACS transfer. Those with non-compatible systems can either be uploaded via CD or analysed at the data collection site. The outcome of the assessment for sarcopenia will define whether a patient is considered to have sarcopenia.
Participants can be identified primarily from the NELA database with confirmation of GI pathology on the radiological report. This can be cross reference against admission logs, acute surgery admission databases, theatre logs for emergency surgery and NELA databases to maximise case capture. Once patients are confirmed to meet the inclusion criteria their data can be gathered into a data collection tool. The CT scan will be extracted and sent for analysis.
All patients meeting inclusion criteria will be identified by the lead researcher in each centre. Frailty scores are already part of standard acute admission clerking proformas in many of the hospitals across the region; as such the researcher's role will be ensure appropriate and complete data capture from existing clinical information sources, but no additional intervention or questioning of patients beyond current standard of care will be required. Patients will be collected across a set time scale as listed above. Baseline demographics and disease factors will be collected as per collection proforma attached as supplementary material.
The Reported Edmonton Frail Scale (REFS) is collected at time of admission as part of routine clinical assessment for surgical admissions. This is a validated, self-reported patient questionnaire that can categorise the degree of frailty. This information is routinely collected in many acute unit or care of the elderly departments. The REFS will enable a consistent method of collecting this data utilising a rapid and well validated tool.
For patients presenting in extremis or unable to complete the score due to an acute state or requirement for prompt treatment, this will be gathered at the next appropriate pre-operative opportunity. Patients unable to complete a REFS given the best opportunity will be excluded, however reasons for exclusion will be recorded.
Sarcopenia, loss of muscle mass or progressive reduction in muscle mass, is one of the central physiological manifestations of frailty resulting in weight loss, weakness and exhaustion. Frailty has both a strong correlation with age as well as significant overlap with disability and co-morbidity. Further factors strongly influencing outcome, 30 day and mortality have been described including polypharmacy, Charlson co-morbidity index, age, not independently mobile, emergency admission and falls. It has been recognised that poor outcomes are multimodal relating to the interplay of co-morbidities, physical functioning and nutrition.
Assessing frailty can be completed using simple questionnaire tools, as well as more complex assessment of co-morbidity, functional status, and disability. There is good evidence the simple tools can be as accurate as formal geriatric assessments.
As sarcopenia relates directly to many manifestations of frailty it can be used as a surrogate marker. One of the favoured ways for diagnosing sarcopenia is using CT morphometric biological markers. This uses an axial image at the level of the 3rd lumbar vertebra (L3) to assess the total or cross-sectional volume of the psoas muscle, giving rise to indices measuring muscle mass, visceral adipose tissue and subcutaneous adipose tissue.
Major abdominal emergency surgery is a high-risk procedure with ongoing audit and outcome monitoring. Currently data collection for UK National Emergency Laparotomy Audit (NELA) is in its fourth year with annual reports into the management and outcomes of emergency laparotomies. Observation and audit of these outcomes remain central to improving service and healthcare both regionally and nationally. Furthermore, this group of patients is not well represented in research and is one of the most understudied surgical cohorts that exist. This is especially the case for patients presenting with an acute surgical diagnosis and are deemed unable to withstand the stress of surgery, and hence pursue a conservative or radiological treatment option. With our ageing, co-morbid population this is becoming increasing common. The diagnosis of frailty and sarcopenia are a significant measurable and modifiable risk factor that impacts on perioperative surgical care, healthcare provider and patient decision-making and most importantly long and short term outcomes. This urgently requires further audit and study.
Work package one (WP1): Retrospective scoping cohort study in acute general surgery
Patient identification The number of patients recruited from each participating hospital will be proportionate to the total number of cases, in accordance with relative annual case volumes (as reported by NELA - in the case of less than 100% case capture, the theoretical 100% case number will be used). This will provide a representative sample of the recruiting region's population.
The most recent laparotomy cases with 1-year follow-up mortality data available will be included at the time of study activation. Data collection over a predicted six week period will be undertaken or until the sample size is reached. Retrospective collection of routinely recorded clinical data will be performed (See appendix data collection tool). This includes, but is not restricted to \[a\] routine clinical variables: patient characteristics, demographic, pathological and physiological variables will be captured in line with NELA data, alongside confounding factors associated with frailty and sarcopenia.
Protocol for measuring muscle radiation attenuation Inclusion: Retrievable CT abdomen/pelvis on an electronic NHS PACS system. CT can be non-contrast or with contrast, supine or prone but must be of sufficient quality for the sarcopenia CT analyses software to handle (Slico-matic™, TomoVision, Magog, Canada ).
Exclusion: CT-scans with large radiation artefacts or with missing parts of muscle tissue on the ventral, dorsal, or both lateral edges of the scan preventing sarcopenia assessment.
Patients meeting inclusion criteria will have their CT extracted and reviewed by a trained independent party. This may through an allocated representative at the base hospital or the CT can be extracted and sent in a fully anonymised format to the central unit for sarcopenia assessment. CT scans obtained via a PACS system can up transferred through secure inter-hospital PACS transfer. Those with non-compatible systems can either be uploaded via CD or analysed at the data collection site. The outcome of the assessment for sarcopenia will define whether a patient is considered to have sarcopenia.
Participants can be identified primarily from the NELA database with confirmation of GI pathology on the radiological report. This can be cross reference against admission logs, acute surgery admission databases, theatre logs for emergency surgery and NELA databases to maximise case capture. Once patients are confirmed to meet the inclusion criteria their data can be gathered into a data collection tool. The CT scan will be extracted and sent for analysis.
All patients meeting inclusion criteria will be identified by the lead researcher in each centre. Frailty scores are already part of standard acute admission clerking proformas in many of the hospitals across the region; as such the researcher's role will be ensure appropriate and complete data capture from existing clinical information sources, but no additional intervention or questioning of patients beyond current standard of care will be required. Patients will be collected across a set time scale as listed above. Baseline demographics and disease factors will be collected as per collection proforma attached as supplementary material.
The Reported Edmonton Frail Scale (REFS) is collected at time of admission as part of routine clinical assessment for surgical admissions. This is a validated, self-reported patient questionnaire that can categorise the degree of frailty. This information is routinely collected in many acute unit or care of the elderly departments. The REFS will enable a consistent method of collecting this data utilising a rapid and well validated tool.
For patients presenting in extremis or unable to complete the score due to an acute state or requirement for prompt treatment, this will be gathered at the next appropriate pre-operative opportunity. Patients unable to complete a REFS given the best opportunity will be excluded, however reasons for exclusion will be recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Frail Elderly Syndrome
Emergencies
Surgery
Sarcopenia
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
COHORT
Study Time Perspective
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrospective arm
Retrospective multicentre cohort with 1 year outcomes available following emergency surgery for NELA eligible gastrointestinal pathology. Please refer to WP1 inclusion and exclusion criteria for eligibility.
CT abdomen +/- pelvis
Intervention Type
DIAGNOSTIC_TEST
Diagnostic CT scan (only if requested by responsible clinicians)
Emergency laparotomy for general surgical pathology
Intervention Type
PROCEDURE
Emergency general surgical laparotomy (defined by the UK NELA body)
Prospective, multicentre arm
10 centre prospective observational arm. Please refer to WP2 inclusion and exclusion criteria for eligibility.
CT abdomen +/- pelvis
Intervention Type
DIAGNOSTIC_TEST
Diagnostic CT scan (only if requested by responsible clinicians)
Edmunton Frailty Score
Intervention Type
DIAGNOSTIC_TEST
Patient completed previously valided questionnaire quantifying frailty.
Emergency laparotomy for general surgical pathology
Intervention Type
PROCEDURE
Emergency general surgical laparotomy (defined by the UK NELA body)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CT abdomen +/- pelvis
Diagnostic CT scan (only if requested by responsible clinicians)
Intervention Type
DIAGNOSTIC_TEST
Edmunton Frailty Score
Patient completed previously valided questionnaire quantifying frailty.
Intervention Type
DIAGNOSTIC_TEST
Emergency laparotomy for general surgical pathology
Emergency general surgical laparotomy (defined by the UK NELA body)
Intervention Type
PROCEDURE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults age over 18
* Route of admission should include all general surgical admission or referrals via emergency department, interdepartmental transfers, direct referrals and GP referrals to an acute general surgical team.
* All patients are required to have had a CT scan abdomen or abdomen and pelvis, supine or prone, with or without contrast.
* All patients are required to have a completed REFS.
* Those treated with operative measure (NCEPOD criteria) or those that would be treated operatively as an emergency, expedited, or urgently on the GI tract including:
* Laparoscopic, open, converted or laparoscopic assisted
* Surgical or radiological procedure or conservative treatments for pathology involving the stomach, small bowel, large bowel as a result of perforation, obstruction, ischaemia, bleeding or abscess.
* Washout or evacuation of intrabdominal haematoma or abscess
* Laparotomy or laparoscopy with no intervention due to inoperable pathology where the intention was to perform definition intervention.
* Bowel resection or repair or conservative treatment due to obstructed or incarcerated incisional umbilical femoral or inguinal hernia.
* Bowel resection/repair or conservative treatment due to obstructing/incarcerated incisional hernias provided the presentation and findings were acute. This will include large incisional hernia repair with division of adhesions.
* Laparoscopic/Open Adhesiolysis or conservative treatment for bowel obstruction
* Return to theatre for repair of substantial dehiscence of major abdominal wound (i.e. "burst abdomen")
* Patients less than 18 years old
* Ambulant or day case admission or outpatient admission only
* No review from an acute surgical team.
* Prisoners or patients under arrest or on remand.
* Isolated gynaecology pathology: pathology of the ovaries, uterus or tubal systems not involving the gastrointestinal tract(GIT) i.e ectopic pregnancy.
* Isolated urology acute abdomen: pathology of the kidneys, ureters or bladder not involving the GIT i.e pyelonephritis, lower urinary tract infections, renal or ureteric stones, bladder malignancy
* Isolated vascular pathology I.e Ruptured aortic aneurysm with no GIT ischaemia, iliac aneurysmal disease.
* Excluded uncomplicated appendicectomy, cholecystectomy and ventral wall, or inguinal hernia.
* Elective laparotomy / laparoscopy
* Diagnostic laparotomy/laparoscopy where no subsequent procedure is performed (NB, if no procedure is performed because of inoperable pathology, the case is included).
* Appendicectomy +/- drainage of localised collection unless the procedure is incidental to a non-elective procedure on the GI tract
* Cholecystectomy +/- drainage of localised collection unless the procedure is incidental to a non-elective procedure on the GI tract (All surgery involving the appendix or gallbladder, including any surgery relating to complications such as abscess or bile leak is excluded. The only exception to this is if carried out as an incidental procedure to a more major procedure. We acknowledge that there might be extreme cases of peritoneal contamination, but total exclusion avoids subjective judgement calls about severity of contamination.)
* Non-elective hernia repair without bowel resection or division of adhesions
* Minor abdominal wound dehiscence unless this causes bowel complications requiring resection
* Non-elective formation of a colostomy or ileostomy as either a trephine or a laparoscopic procedure (NB: if a midline laparotomy is performed, with the primary procedure being formation of a stoma then this should be included)
* Vascular surgery, including abdominal aortic aneurysm repair
* Caesarean section or obstetric laparotomies
* Gynaecological laparotomy
* Ruptured ectopic pregnancy, or pelvic abscesses due to pelvic inflammatory disease
* Laparotomy/laparoscopy for pathology caused by blunt or penetrating trauma
* All surgery relating to organ transplantation (including returns to theatre for any reason following transplant surgery)
* Surgery relating to sclerosing peritonitis
* Surgery for removal of dialysis catheters
* Laparotomy/laparoscopy for oesophageal pathology
* Laparotomy/laparoscopy for pathology of the spleen, renal tract, kidneys, liver, gall bladder and biliary tree, pancreas or urinary tract
* Returns to theatre for complications (eg bowel injury, haematoma, collection) following non-GI surgery are excluded. i.e returns to theatre following renal, urological, gynaecological, vascular, hepatic, pancreatic, splenic surgery are excluded.
* Route of admission should include all general surgical admission or referrals via emergency department, interdepartmental transfers, direct referrals and GP referrals to an acute general surgical team.
* All patients are required to have had a CT scan abdomen or abdomen and pelvis, supine or prone, with or without contrast.
* All patients are required to have a completed REFS.
* Those treated with operative measure (NCEPOD criteria) or those that would be treated operatively as an emergency, expedited, or urgently on the GI tract including:
* Laparoscopic, open, converted or laparoscopic assisted
* Surgical or radiological procedure or conservative treatments for pathology involving the stomach, small bowel, large bowel as a result of perforation, obstruction, ischaemia, bleeding or abscess.
* Washout or evacuation of intrabdominal haematoma or abscess
* Laparotomy or laparoscopy with no intervention due to inoperable pathology where the intention was to perform definition intervention.
* Bowel resection or repair or conservative treatment due to obstructed or incarcerated incisional umbilical femoral or inguinal hernia.
* Bowel resection/repair or conservative treatment due to obstructing/incarcerated incisional hernias provided the presentation and findings were acute. This will include large incisional hernia repair with division of adhesions.
* Laparoscopic/Open Adhesiolysis or conservative treatment for bowel obstruction
* Return to theatre for repair of substantial dehiscence of major abdominal wound (i.e. "burst abdomen")
* Patients less than 18 years old
* Ambulant or day case admission or outpatient admission only
* No review from an acute surgical team.
* Prisoners or patients under arrest or on remand.
* Isolated gynaecology pathology: pathology of the ovaries, uterus or tubal systems not involving the gastrointestinal tract(GIT) i.e ectopic pregnancy.
* Isolated urology acute abdomen: pathology of the kidneys, ureters or bladder not involving the GIT i.e pyelonephritis, lower urinary tract infections, renal or ureteric stones, bladder malignancy
* Isolated vascular pathology I.e Ruptured aortic aneurysm with no GIT ischaemia, iliac aneurysmal disease.
* Excluded uncomplicated appendicectomy, cholecystectomy and ventral wall, or inguinal hernia.
* Elective laparotomy / laparoscopy
* Diagnostic laparotomy/laparoscopy where no subsequent procedure is performed (NB, if no procedure is performed because of inoperable pathology, the case is included).
* Appendicectomy +/- drainage of localised collection unless the procedure is incidental to a non-elective procedure on the GI tract
* Cholecystectomy +/- drainage of localised collection unless the procedure is incidental to a non-elective procedure on the GI tract (All surgery involving the appendix or gallbladder, including any surgery relating to complications such as abscess or bile leak is excluded. The only exception to this is if carried out as an incidental procedure to a more major procedure. We acknowledge that there might be extreme cases of peritoneal contamination, but total exclusion avoids subjective judgement calls about severity of contamination.)
* Non-elective hernia repair without bowel resection or division of adhesions
* Minor abdominal wound dehiscence unless this causes bowel complications requiring resection
* Non-elective formation of a colostomy or ileostomy as either a trephine or a laparoscopic procedure (NB: if a midline laparotomy is performed, with the primary procedure being formation of a stoma then this should be included)
* Vascular surgery, including abdominal aortic aneurysm repair
* Caesarean section or obstetric laparotomies
* Gynaecological laparotomy
* Ruptured ectopic pregnancy, or pelvic abscesses due to pelvic inflammatory disease
* Laparotomy/laparoscopy for pathology caused by blunt or penetrating trauma
* All surgery relating to organ transplantation (including returns to theatre for any reason following transplant surgery)
* Surgery relating to sclerosing peritonitis
* Surgery for removal of dialysis catheters
* Laparotomy/laparoscopy for oesophageal pathology
* Laparotomy/laparoscopy for pathology of the spleen, renal tract, kidneys, liver, gall bladder and biliary tree, pancreas or urinary tract
* Returns to theatre for complications (eg bowel injury, haematoma, collection) following non-GI surgery are excluded. i.e returns to theatre following renal, urological, gynaecological, vascular, hepatic, pancreatic, splenic surgery are excluded.
Exclusion Criteria
* If multiple procedures are performed on different anatomical sites within the abdominal/pelvic cavity, the patient would be included if the major procedure is general surgical.
* Non-elective colonic resection with hysterectomy for a fistulating colonic cancer would be included as the bowel resection is the major procedure
* Bowel resection at the same time as emergency abdominal aortic aneurysm repair would not be included as the aneurysm repair is the major procedure
* The subjects are required to have had an acute admission, inpatient stay, formal ward admission, review and diagnosis of acute GIT surgical pathology under an acute surgical team.
* Non-elective colonic resection with hysterectomy for a fistulating colonic cancer would be included as the bowel resection is the major procedure
* Bowel resection at the same time as emergency abdominal aortic aneurysm repair would not be included as the aneurysm repair is the major procedure
* The subjects are required to have had an acute admission, inpatient stay, formal ward admission, review and diagnosis of acute GIT surgical pathology under an acute surgical team.
Minimum Eligible Age
18 Years
Maximum Eligible Age
100 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Southampton NHS Foundation Trust
OTHER
Sponsor Role
collaborator
Basingstoke and North Hampshire Hospital
UNKNOWN
Sponsor Role
collaborator
Dorset County Hospital NHS Foundation Trust
OTHER_GOV
Sponsor Role
collaborator
Poole Hospital NHS Foundation Trust
OTHER
Sponsor Role
collaborator
Portsmouth Hospitals NHS Trust
OTHER_GOV
Sponsor Role
collaborator
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
OTHER_GOV
Sponsor Role
collaborator
Salisbury NHS Foundation Trust
OTHER_GOV
Sponsor Role
collaborator
University of Southampton
OTHER
Sponsor Role
collaborator
National Institute for Health Research, United Kingdom
OTHER_GOV
Sponsor Role
collaborator
Hampshire Hospitals NHS Foundation Trust
OTHER
Sponsor Role
collaborator
Isle of Wight NHS Trust
OTHER
Sponsor Role
collaborator
Yeovil District Hospital NHS Foundation Trust
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nathan Curtis
Clinical Research Fellow
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malcolm West, MD PhD MRCS
Role: PRINCIPAL_INVESTIGATOR
University of Southampton
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hampshire Hospitals NHS Foundation Trust
Basingstoke, , United Kingdom
Site Status
RECRUITING
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Bournemouth, , United Kingdom
Site Status
RECRUITING
Dorset County Hospital NHS Foundation Trust
Dorchester, , United Kingdom
Site Status
RECRUITING
Isle of Wight NHS Trust
Newport, , United Kingdom
Site Status
RECRUITING
Poole Hospital NHS Foundation Trust
Poole, , United Kingdom
Site Status
RECRUITING
Portsmouth Hospitals NHS Trust
Portsmouth, , United Kingdom
Site Status
RECRUITING
Salisbury NHS Foundation Trust
Salisbury, , United Kingdom
Site Status
RECRUITING
University Hospital Southampton NHS Foundation Trust
Southampton, , United Kingdom
Site Status
RECRUITING
Hampshire Hospitals NHS Foundation Trust
Winchester, , United Kingdom
Site Status
RECRUITING
Yeovil District Hospital NHS Foundation Trust
Yeovil, , United Kingdom
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
United Kingdom
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Alex Tzivanakis
Role: primary
Nick Baylem
Role: primary
Ben Stubbs
Role: primary
Mike Terry
Role: primary
Paul Frogatt
Role: primary
Simon Toh
Role: primary
Amanda Bond
Role: primary
Dave Berry
Role: primary
Jack Broadhurst
Role: primary
Nader Francis
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
224891
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Emergency Surgery in the Elderly: Comparison of Frailty Index and Surgical Risk Score
NCT02825082
COMPLETED
Intraoperative Systemic Arterial Hypotension Secondary to Beach Positioning
NCT03451565
UNKNOWN
Fragility and Programmed Cardiovascular Surgery (EcoSarco)
NCT04110509
COMPLETED
Peripheral and Mesenteric Perfusion in Elective Surgical Patients
NCT03395483
COMPLETED
Frailty, Physical Capacity and Lung Function in Postoperative Cardiac Surgery Patients
NCT06247358
RECRUITING
Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy
NCT00911391
COMPLETED
PHASE3
The Effects of Prolonged Head-Down Tilt Lithotomy Position on Lower Limb Haemodynamics
NCT06036641
RECRUITING
Cardiac Surgery and Postoperative Organ Dysfunction
NCT05529212
UNKNOWN
The Relationship Between Preoperative Frailty and Postoperative AKI and the Mediating Effect of Intraoperative BP
NCT07030179
RECRUITING
Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy
NCT06130436
COMPLETED
NA
Tissue Perfusion During Emergency Laparotomy
NCT04403425
UNKNOWN
Remote Ischemic Preconditioning Before Abdominal Surgery
NCT01340742
WITHDRAWN
NA
Use of Perfusion Index Change as a Predictor of Hypotension During Propofol Sedation in Adult Patients Undergoing Hip Surgery Under Spinal Anesthesia: A Prospective Observational Study
NCT03556969
COMPLETED
Prognostic Value of Exhaled Isoprene Levels for Morbidity and Functional Outcome in Cardiosurgical Patients
NCT06175429
RECRUITING
Pre-Frailty Risk in Cardiovascular Surgery
NCT02829203
COMPLETED
Low Psoas Index and Cardiac Assistance: No Excess Mortality at D28 Post Implantation
NCT05612555
COMPLETED
Endothelial Dysfunction As A Predictor Of Perioperative Outcome
NCT00384683
COMPLETED
Postoperative Gastrointestinal Dysfunction After High Risk Surgery
NCT05867043
UNKNOWN
Extended Care in High-Risk Surgical Patient (EXCARE) Pathway in High-risk Surgical Population
NCT04187664
UNKNOWN
NA
DIEP Flap Surgery and Intraabdominal Pressure
NCT05764577
COMPLETED
Impact of Hand Grip Strength on Length of Hospital Stay After Cardiac Surgery Among Elderly Patients
NCT05546671
RECRUITING
Association Between Muscular Tissue Oxygen Saturation and AKI in Older Patients Undergoing Major Abdominal Surgery
NCT04954066
COMPLETED
Hypotension Prediction During Cardiac Surgery Postoperative Period
NCT05840432
UNKNOWN
Ability of Cardio Q for Prediction of Hypotension
NCT03882697
COMPLETED